Reply  by Mørk, Cato & Kvernebo, Knut
Reply
We thank Davis et al for their comments on our study
``Microvascular arteriovenous shunting is a probable pathogenetic
mechanism in erythromelalgia'' (Mùrk et al, 2000) and offer the
following reply.
There is a considerable confusion on the diagnostic criteria
and nomenclature of erythromelalgia (EM) (Mùrk and Kvernebo,
2000). Since we started studying EM patients in 1983, we have
used the clinical inclusion criteria de®ned by Thompson
(Thompson et al, 1979): (1) burning extremity pain, (2) pain
aggravated by warming, (3) pain relieved by cooling, (4) erythema
of affected skin, and (5) increased temperature of affected skin. Up
to now we have collected 144 patients ful®lling these criteria.
On the basis of the history and clinical examination, we have
proposed a clinical classi®cation, and based on physiologic studies
and clinical observations in selected patients, we have proposed skin
microvascular arteriovenous shunting as a common pathogenetic
mechanism (Kvernebo, 1998).
We do not consider EM to be a separate disease entity, but a
symptom complex, a condition, caused by one speci®c patho-
physiologic response, AV shunting. This view is analogous to
the recognized fact that in¯ammation is not a speci®c disease,
but a physiologic response to stimuli such as infection, trauma,
or tumor.
The ®ndings by Sandroni et al (1999) of local skin
temperature exceeding core temperature are interesting. We
have not observed such a situation, and in our experience
maximal skin temperature recorded during EM symptoms,
induced by whole body heating, has been 36.4°C. Local skin
temperature is the result of a balance between: (1) heating by
local perfusion, (2) heating by local metabolism, and (3) heat
gain from or loss to the environment. The ®ndings by the
Mayo group must be caused by a combination of the three
factors, and the relative importance of each is uncertain (Davis
et al, 2000). Did the reported patients have local infection or
in¯ammation? What was the environmental temperature? Our
hypothesis is that AV shunting increases the relative importance
of heat gain by local perfusion.
A complex interaction of local and central mechanisms
regulates the vascular tone in the cutaneous microcirculation.
Small-®ber neuropathy can affect distribution of ¯ow and create
shunting, whereas tissue hypoxia secondary to EM can induce
neuropathy. In some patients, neuropathy and shunting is
probably coexisting. At present we are performing neurophy-
siology studies in EM patients with known AV shunting.
To stimulate advances in this ®eld, we see a need for an
international consensus conference clarifying nomenclature and
diagnostic criteria.
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